The Differential Diagnosis of Depression: Relevance of Positron Emission Tomography Studies of Cerebral Glucose Metabolism to the Bipolar-Unipolar Dichotomy

JAMA: The Journal of the American Medical Association

Volumn 258, Issue 10, 1987, Pages 1368-1374

  Schwartz, Jeffrey M ^a   Baxter, Lewis R ^a   Mazziotta, John C ^a   Gerner, Robert H ^a   Phelps, Michael E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; DIAGNOSIS; GLUCOSE BRAIN LEVEL; HUMAN; MAJOR DEPRESSION; MANIC DEPRESSIVE PSYCHOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

BIPOLAR DISORDER; BRAIN; DEOXYGLUCOSE; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 84944366350     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1987.03400100102031     Document Type: Article

References (104)

1. Boyd JH, Weissman MM: Epidemiology, in Paykel ES (ed): Handbook of Affective Disorders. New York, Guilford Press, 1982, pp 109-125.
2. Myers JK, Weissman MM, Tischler GC, et al: Six month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry 1984;41: 959-967.
3. Shapiro S, Skinner EA, Kessler LG, et al: Utilization of health and mental health services. Arch Gen Psychiatry 1984;41:971-978.
4. Tallarida RJ: MPD 85: Most Prescribed Drugs 1985. Philadelphia, WB Saunders Co, 1985.
5. American Psychiatric Association Task Force on Nomenclature and Statistics: DSM III: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.
6. Goodwin DW, Guze SB: Psychiatric Diagnosis, ed 3. New York, Oxford University Press Inc, 1984.
7. Klein DF, Gittelman R, Quitkin F, et al: The diagnosis of affective disorders: Review of nosological schemata, in Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. Baltimore, Williams & Wilkins, 1980, pp 251-267.
8. Andreasen NC: Concepts, diagnosis and classification, in Paykel ES (ed): Handbook of Affective Disorders. New York, Guilford Press, 1982, pp 24-44.
9. Liebowitz MR, Klein DF, Quitkin FM, et al: Clinical implications of diagnostic subtypes of depression, in Post RM, Ballenger JC (eds): Neurobiology of Mood Disorders. Baltimore, Williams & Wilkins, 1984, pp 107-120.
10. Avery DH, Wilson LG, Dunner DL: Diagnostic subtypes of depression as predictors of therapeutic response, in Clayton PJ, Barrett JE (eds): Treatment of Depression: Old Controversies and New Approaches. New York, Raven Press, 1983, pp 193-205.
11. Insel TR, Murphy DL: Pharmacologic response and subgroups of patients with affective illness, in Post RM, Ballenger JC (eds): Neurobiology of Mood Disorders. Baltimore, Williams & Wilkins, 1984, pp 854-865.
12. Schildkraut JJ, Orsulak PJ, Schatzberg AF, et al: Laboratory tests for discriminating subtypes of depressive disorders based on measurements of catecholamine metabolism, in Zales MR (ed): Affective and Schizophrenic Disorders. New York, Brunner/Mazel Inc, 1983, pp 103-123.
13. Andreasen NC: The clinical differentiation of affective and schizophrenic disorders, in Zales MR (ed): Affective and Schizophrenic Disorders. New York, Brunner/Mazel Inc, 1983, pp 29-52.
14. Baxter LR Jr, Phelps ME, Mazziotta JC, et al: Cerebral metabolic rates for glucose in mood disorders: Studies with positron emission tomography and fluorodeoxyglucose F18. Arch Gen Psychiatry 1985;42:441-447.
15. Schildkraut JJ, Schatzberg AF, Orsulak PJ, et al: Biological discrimination of subtypes of depression, in Davis JM, Maas JW (eds): The Affective Disorders. Washington, DC, American Psychiatric Press, 1983, pp 31-51.
16. Kendell RE: Historical introduction, in The Classification of Depressive Illnesses. London, Oxford University Press, 1968, pp 1-17.
17. Klerman GC: History and development of modern concepts of affective illness, in Post RM, Ballenger JC (eds): Neurobiology of Mood Disorders. Baltimore, Williams & Wilkins, 1984, pp 1-19.
18. Kiloh LG, Garside RF: The independence of neurotic depression and endogenous depression. Br J Psychiatry 1963;109:451-463.
19. Arieti S: Affective disorders: Manic-depressive psychosis and psychotic depression: Manifest symptomatology, psychodynamics, sociological factors, and psychotherapy, in Arieti S (ed): Adult Clinical Psychiatry, vol 3, in American Handbook of Psychiatry. New York, Basic Books, 1974, pp 449-490.
20. Lewis AJ: Melancholia: Prognostic study and case material. J Ment Sci 1936;82:488-558.
21. Robins E, Guze SB: Classification of affective disorders: The primary-secondary, the endogenous-reactive, and the neurotic-psychotic concepts, in Williams TA, Katz MM, Shield JA Jr (eds): Recent Advances in the Psychobiology of the Depressive Illnesses, publication HSM 70-9053. US Government Printing Office, 1972, pp 283-293.
22. Akiskal HS, Bitar AH, Puzantian VR, et al: The nosological status of neurotic depression. Arch Gen Psychiatry 1978;35:756-766.
23. Leff MJ, Roatch JF, Bunney WE Jr: Environmental factors preceding the onset of severe depressions. Psychiatry 1970;33:293-311.
24. Guze SB, Woodruff RA, Clayton PJ: Secondary affective disorder: A study of 95 cases. Psychol Med 1971;1:426-428.
25. Kupfer DJ, Detre TP: Tricyclic and monamineoxidase-inhibitor antidepressants: Clinical use, in Iversen LL, Iversen SD, Snyder SH (eds): Handbook of Psychopharmacology. New York, Plenum Press, 1978, vol 14, pp 199-232.
26. Leonhard K, Korff I, Shulz H: Die temperamente in den Familien der monopolaren und bipolaren phasischen Psychosen. Psychiatr Neurol 1962;143:416-434.
27. Angst J: Zur Atiologie und Nosologie endogener depressives psychosen. Monogr Neurol Psychiatr 1966;112:1-118.
28. Perris C: A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatr Scand 1966;42(suppl 194):1-188.
29. Winokur G, Clayton PJ, Reich T: Manic-Depressive Illness. St Louis, CV Mosby Co, 1969.
30. Rice J, Reich T, Andreasen NC, et al: The familial transmission of bipolar illness. Arch Gen Psychiatry 1987;44:441-447.
31. Nurnberger JI, Gershon ES: Genetics of affective disorders, in Post RM, Ballenger JC (eds): Neurobiology of Mood Disorders. Baltimore, Williams & Wilkins. 1984, pp 76-101.
32. Gershon ES: The genetics of affective disorders, in Grinspoon L (ed): Psychiatry Update. Washington, DC, American Psychiatric Press, 1983, vol 2, pp 434-457.
33. Weissman MM, Gershon ES, Kidd KK, et al: Psychiatric disorders in the relatives of probands with affective disorders. Arch Gen Psychiatry 1984;41:13-21.
34. Clayton PJ: The prevalence and course of affective disorders, in Davis JM, Maas JW (eds): The Affective Disorders. Washington, DC, American Psychiatric Press, 1983, pp 193-201.
35. Angst J, Grof P: The course of monopolar depressions and bipolar psychoses, in Villeneuve A (ed): Lithium in Psychiatry: A Synopsis. Quebec, Les Presses de L’Universite Laval, 1976, pp 93-103.
36. Goodwin FK, Murphy DL, Dunner DL, et al: Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972;129:4447.
37. Klein DF, Gittelman R, Quitkin F, et al: Review of the literature on mood-stabilizing drugs, in Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. Baltimore, Williams & Wilkins, 1980, pp 268-408.
38. Perris C: The distinction between bipolar and unipolar affective disorders, in Paykel ES (ed): Handbook of Affective Disorders. New York, Guilford Press, 1982, pp 45-58.
39. Loranger AW, Levine PM: Age at onset of bipolar affective illness. Arch Gen Psychiatry 1978;35:1345-1348.
40. Dunner DL, Gershon ES, Goodwin FK: Heritable factors in the severity of affective illness. Biol Psychiatry 1976;11:31-42.
41. Angst J: Clinical typology of bipolar illness, in Belmaker RH, van Praag HM (eds): Mania: An Evolving Concept. Jamaica, NY, SP Medical & Scientific Books, 1980, pp 61-76.
42. Weissman MM, Klerman GC: Sex differences in the epidemiology of depression. Arch Gen Psychiatry 1977;34:98-111.
43. Perris C, d’Elia G: Mortality, suicide, and lifecycles: A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatry Scand Suppl 1966;42:172-183.
44. Guze SB, Robins E: Suicide and primary affective disorders. Br J Psychiatry 1970;117:437-438.
45. Endicott J, NeeJ, Andreasen NC, et al: Bipolar II: Combine or keep separate? J Affective Disord 1985;8:17-28.
46. Brockington IF, Altman E, Hillier V, et al: The clinical picture of bipolar affective disorder in its depressed phase. Br J Psychiatry 1982;141: 558-562.
47. Beigel A, Murphy DL: Unipolar and bipolar affective illness. Arch Gen Psychiatry 1971;24: 215-220.
48. Allen MG, Cohen S, Pollin W, et al: Affective illness in veteran twins: A diagnostic review. Am J Psychiatry 1974;131:1234-1239.
49. Bertelsen A, Harvald B, Hauge M: A Danish twin study of manic-depressive disorders. Br J Psychiatry 1977;130:330-351.
50. Andreasen NC, Rice J, Endicott J, et al: Familial rates of affective disorder: A report from the National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry 1987;44:461-469.
51. Mendlewicz J, Rainer JD: Adoption study supporting genetic transmission in manic-depressive illness. Nature 1977;268:327-329.
52. Angst J, Frey R, Lohmeyer B, et al: Bipolar manic-depressive psychoses: Results of a genetic investigation. Hum Genet 1980;55:237-254.
53. Jakimow-Venulet B: Hereditary factors in the pathogenesis of affective illness. Br J Psychiatry 1981;139:450-456.
54. Tsuang MT, Faraone SV, Fleming JA: Familial transmission of major affective disorders: Is there evidence supporting the distinction between unipolar and bipolar disorders? Br J Psychiatry 1985;146:268-271.
55. Dunner DL: Recent genetic studies of bipolar and unipolar depression, in Davis JM, Maas JW (eds): The Affective Disorders. Washington, DC, American Psychiatric Press, 1983, pp 183-191.
56. Mendels J: Lithium in the treatment of depression. Am J Psychiatry 1976;133:373-378.
57. Carroll BJ: Prediction of treatment outcome with lithium. Arch Gen Psychiatry 1979;36: 870-878.
58. Prien RF, Kupfer DJ, Mansky PA, et al: Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 1984;41:1096-1104.
59. Ramsey TA, Mendels J: Lithium in the acute treatment of depression, in Johnson FN (ed): Handbook of Lithium Therapy. Lancaster, England, MTP Press Ltd, 1980, pp 17-25.
60. Mendels J, Ramsey A, Dyson WL, et al: Lithium as an antidepressant. Arch Gen Psychiatry 1979;36:845-846.
61. Dunner DL, Stallone F, Fieve RR: Lithium carbonate and affective disorders. Arch Gen Psychiatry 1976;33:117-120.
62. Kupfer DJ, Pikar D, Himmelhoch JM, et al: Are there two types of unipolar depression? Arch Gen Psychiatry 1975;32:866-871.
63. Dunner DL: Unipolar and bipolar depression: Recent findings from clinical and biologic studies, in Mendels J, Amsterdam JD (eds): The Psychobiology of Affective Disorders. New York, S Karger AG, 1980, pp 11-24.
64. Pickar D, Lowdry RW, Zis AP, et al: Mania and hypomania during antidepressant pharmacotherapy: Clinical and research implications, in Post RM, Ballenger JC (eds): Neurobiology of Mood Disorders. Baltimore, Williams & Wilkins, 1984, pp 836-845.
65. Bunney WE Jr: Psychopharmacology of the switch process in affective illness, in Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 1249-1259.
66. Wehr TA, Goodwin FK: Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555-559.
67. Kukopulos A, Reginaldi D, Caddonada P, et al: Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980;13:156-167.
68. Dunner DL, Dwyer T, Fieve RR: Depressive symptoms in patients with unipolar and bipolar affective disorder. Compr Psychiatry 1976;17: 447-451.
69. Lipton MA: The evolution of the biological understanding of affective and schizophrenic disorders, in Zales MR (ed): Affective and Schizophrenic Disorders. New York, Brunner/Mazel Inc, 1983, pp 5-28.
70. Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress New York, Raven Press, 1978.
71. Schildkraut JJ: The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 1965;122:509-522.
72. Schildkraut JJ, Orsulak PJ, Schatzberg AF, et al: Toward a biochemical classification of depressive disorders: I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Arch Gen Psychiatry 1978;35:1427-1433.
73. Schildkraut JJ, Orsulak PJ, LaBrie RA, et al: Toward a biochemical classification of depressive disorders: II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Arch Gen Psychiatry 1978;35:1436-1439.
74. Sacchetti E, Vita A, Conte G, et al: Lithium prophylaxis in major affective disorders: On the specificity and sensitivity of some ’new’ predictors of treatment outcome, in Corsini GV (ed): Current Trends in Lithium and Rubidium Therapy. Lancaster, England, MTP Press Ltd, 1984, pp 165-187.
75. Muscettola G, Potter WZ, Pickar D, et al: Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. Arch Gen Psychiatry 1984;41:337-342.
76. Zis AP, Cowdry RW, Wehr TA, et al: Tricyclicinduced mania and MHPG excretion. Psychiatr Res 1979;1:93-99.
77. Phelps ME, Schelbert HR, Mazziotta JC: Positron computed tomography for studies of myocardial and cerebral function. Ann Intern Med 1983;98:339-359.
78. Phelps ME, Mazziotta JC, Huang SC: Study of cerebral function with positron computed tomography. J Cereb Blood Flow Metab 1982;2:113-162.
79. Phelps ME, Mazziotta JC: Positron emission tomography: Human brain function and biochemistry. Science 1985;228:799-809.
80. Phelps ME, Mazziotta JC, Baxter L, et al: Positron emission tomographic study of affective disorders: Problems and strategies. Ann Neurol 1984;15(suppl):S149-S156.
81. Buchsbaum MS, Ingvar DH, Kessler R, et al: Cerebral glucography with positron tomography: Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 1982;39:251-259.
82. Buchsbaum MS, DeLisi LE, Holcomb HH, et al: Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 1984;41:1159-1166.
83. Widen L, Blomquist G, Greitz T, et al: PET studies of glucose metabolism in patients with schizophrenia. AJNR 1983;4:550-552.
84. Farkas T, Wolf AP, Jaeger J, et al: Regional brain glucose metabolism in chronic schizophrenia, a positron emission transaxial tomographic study. Arch Gen Psychiatry 1984;41:293-300.
85. Wolkin A, Jaeger J, Brodie JD, et al: Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 1985;142: 564-571.
86. Reiman EM, Raichle ME, Butler FK, et al: A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 1984;310:683-685.
87. Gur RE: Positron emission tomography in psychiatric disorders. Psychiatr Ann 1985;145: 268-271.
88. Buchsbaum MS, Wu J, DeLisi LE, et al: Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affective Disord 1986;10:137-152.
89. Phelps ME, Huang SC, Hoffman EJ, et al: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 1979;6:371-388.
90. Huang SC, Phelps ME, Hoffman EJ, et al: Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980; 238:E69-E82.
91. Phelps ME, Hoffman EF, Mullani NA, et al: Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med 1975;16:210-224.
92. Reivich M, Kuhl D, Wolf A, et al: The (18F) fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127-137.
93. Sokoloff L, Reivich M, Kennedy C: The (14C) deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthesized rat. J Neurochem 1977;28:897-916.
94. Kety SS: The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951;3:1-41.
95. Siesjo BK: Brain Energy Metabolism. New York, John Wiley & Sons Inc, 1978, pp 101-130.
96. Mathew RJ, Meyer JS, Francis DJ, et al: Cerebral blood flow in depression. Am J Psychiatry 1980;137:1449-1450.
97. Gustafson L, Risberg J, Silfuerskiold P: Cerebral blood flow in dementia and depression. Lancet 1981;1:275.
98. Gustafson L, Risberg J, Silferskiold P: Regional cerebral blood flow in organic dementia and affective disorders. Adv Biol Psychiatry 1981;6: 109-116.
99. Gur RE, Skolnick BE, Gur RC, et al: Brain function in psychiatric disorders: II. Regional cerebral blood flow in medicated unipolar depressives. Arch Gen Psychiatry 1984;41:695-699.
100. Raichle ME, Taylor JR, Herscovitch P, et al: Brain circulation and metabolism in depression, in Greitz T, Ingvar DH, Widen L (eds): The Metabolism of the Human Brain Studied With Positron Emission Tomography. New York, Raven Press, 1985, pp 453-456.
101. Fuster JM: The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe. New York, Raven Press, 1980, pp 5-39.
102. Nauta WJH, Domesick VB: Afferent and efferent relationships of the basal ganglia, in Evarts E (ed): Functions of the Basal Ganglia, CIBA Foundation symposium 107. London, Pitman Bks Ltd, 1984, pp 3-29.
103. Goldman PS, Nauta WJH: An intricately patterned prefrontocaudate projection in the rhesus monkey. J Comp Neurol 1977;171:369-386.
104. Evens RG, Siegel BA, Welch MJ, et al: Cost analyses of positron emission tomography for clinical use. AJR 1983;141:1073-1076.